Get the tools used by (smart)2 investors.

EBITDA Forecast (FINBOX) for Sight Sciences Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

SGHT: Sight Sciences Inc

Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases. It op...

2.57 USD
Price
USD
Fair Value
Upside
2.17 - 8.45
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Sight Sciences Inc's EBITDA Forecast (FINBOX):

Dec 2026Dec 2028Dec 2030Dec 2032Dec 2034-50 M-40 M-30 M-20 M

Performance Summary
  • Sight Sciences's ebitda forecast for the next fiscal year is -43.798 million

How does Sight Sciences's EBITDA Forecast (FINBOX) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Sight Sciences Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: EBITDA Forecast

Hide this widget
ebitda_proj
Slug
number
Datatype
text
Format
current
Default Period
FY, Q
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to EBITDA Forecast (FINBOX) in the forecast category include:

  • NAV Forecast Mean Consensus - The lowest Net Asset Value (NAV) forecast submitted by any analyst for the company.
  • AFFO / Share Forecast Count of Estimates - The number of analysts publishing an AFFO / share Forecast for the stock.
  • Positive EPS Revisions Ratio, Last 30 Days - Represents a ratio of analysts that have revised EPS forecasts upwards divided by a count of all analysts covering the company in the last 30 days (can be 0).
  • Consensus AFFO, Actual - Reported AFFO including any adjustments for unusual items proposed by management. This metric is useful for analyst forecast vs actual analysis since deciding which add backs are truly "unusual" is subjective. Consider using "affo" slug instead for other analysis.
View Full List

Search for metric or datapoint

EBITDA Forecast

Forecasted earnings before interest, taxes, depreciation and amortization (EBITDA).

Definition of EBITDA Forecast (FINBOX)

Hide this widget
Forecasted earnings before interest, taxes, depreciation and amortization (EBITDA).

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-282 M1.218 B2.718 B5.64 B0200400600

The chart above depicts the distribution of ebitda forecast (finbox) for companies operating in the Healthcare sector in the Developed economic region. Over 1,720 companies were considered in this analysis, and 1,655 had meaningful values. The average ebitda forecast (finbox) of companies in the sector is 170.7 M with a standard deviation of 659.4 M.

Sight Sciences Inc's EBITDA Forecast (FINBOX) of -43.798 M ranks in the 18.5% percentile for the sector. The following table provides additional summary stats:

EBITDA Forecast (FINBOX) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents1,723
Included Constituents1,655
Min-324.4 M
Max5.59 B
Median4.243 M
Mean170.7 M
Standard Deviation659.4 M

You can find companies with similar ebitda forecast (finbox) using this stock screener.

All rights reserved. Terms Of Use